Axitinib for the Management of Metastatic Renal Cell Carcinoma
Bernard Escudier(Institut Gustave Roussy), Martin Gore(Institute of Cancer Research)
Cited by 147
Related Papers
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k
Axitinib for the Management of Metastatic Renal Cell Carcinoma
|Drugs in R&D|2011|13